SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001633070-23-000004
Filing Date
2023-03-30
Accepted
2023-03-30 08:22:38
Documents
14
Period of Report
2023-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axla-20230330.htm   iXBRL 8-K 34036
2 EX-99.1 ex9912022q4.htm EX-99.1 76875
6 GRAPHIC imagea.jpg GRAPHIC 14688
  Complete submission text file 0001633070-23-000004.txt   273834

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axla-20230330.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axla-20230330_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axla-20230330_pre.xml EX-101.PRE 13045
8 EXTRACTED XBRL INSTANCE DOCUMENT axla-20230330_htm.xml XML 4740
Mailing Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139 617-868-0949
Axcella Health Inc. (Filer) CIK: 0001633070 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38901 | Film No.: 23777263
SIC: 2836 Biological Products, (No Diagnostic Substances)